Download logo
The launch will take place at the CSIR in Pretoria and marks an important milestone in efforts to strengthen South Africa’s pharmaceutical innovation ecosystem and expand domestic capacity to develop and manufacture critical medicines and pharmaceutical products.
FuturePharma is an open-access pharmaceutical innovation and manufacturing facility established by the CSIR to support the development and production of active pharmaceutical ingredients (APIs) and other pharmaceutical technologies, while strengthening South Africa’s pharmaceutical value chain.
The facility aims to bridge the gap between promising laboratory research and the development, scale-up and commercialisation of pharmaceutical technologies. It will provide researchers, innovators and industry partners with access to specialised infrastructure and expertise to advance technologies towards manufacturing, while supporting technology transfer and skills development.
The facility will also support local API and medicine production, helping to reduce dependence on imports and strengthen security of supply. In addition, it will contribute to South Africa’s preparedness for future pandemics and health emergencies by strengthening local pharmaceutical capabilities.
The launch will bring together members of the Executive and senior representatives from government, the science and innovation community, and industry.
President Ramaphosa will officiate the launch as follows:
Date: Wednesday, 7 October 2026
Time: 10h00
Venue: CSIR International Convention Centre, Pretoria
Distributed by APO Group on behalf of The Presidency of the Republic of South Africa.
This website uses cookies.
